BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 12633995)

  • 1. New insights into fragile X syndrome: from molecules to neurobehaviors.
    Jin P; Warren ST
    Trends Biochem Sci; 2003 Mar; 28(3):152-8. PubMed ID: 12633995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragile X mental retardation: misregulation of protein synthesis in the developing brain?
    Feng Y
    Microsc Res Tech; 2002 May; 57(3):145-7. PubMed ID: 12112449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered synaptic plasticity in a mouse model of fragile X mental retardation.
    Huber KM; Gallagher SM; Warren ST; Bear MF
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7746-50. PubMed ID: 12032354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fragile X syndrome: from molecular genetics to neurobiology.
    Willemsen R; Oostra BA; Bassell GJ; Dictenberg J
    Ment Retard Dev Disabil Res Rev; 2004; 10(1):60-7. PubMed ID: 14994290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The C terminus of fragile X mental retardation protein interacts with the multi-domain Ran-binding protein in the microtubule-organising centre.
    Menon RP; Gibson TJ; Pastore A
    J Mol Biol; 2004 Oct; 343(1):43-53. PubMed ID: 15381419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway.
    Jin P; Zarnescu DC; Ceman S; Nakamoto M; Mowrey J; Jongens TA; Nelson DL; Moses K; Warren ST
    Nat Neurosci; 2004 Feb; 7(2):113-7. PubMed ID: 14703574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A decade of molecular studies of fragile X syndrome.
    O'Donnell WT; Warren ST
    Annu Rev Neurosci; 2002; 25():315-38. PubMed ID: 12052912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of FMRP-associated mRNA granules and requirement of microtubules for activity-dependent trafficking in hippocampal neurons.
    Antar LN; Dictenberg JB; Plociniak M; Afroz R; Bassell GJ
    Genes Brain Behav; 2005 Aug; 4(6):350-9. PubMed ID: 16098134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential translation and fragile X syndrome.
    Vanderklish PW; Edelman GM
    Genes Brain Behav; 2005 Aug; 4(6):360-84. PubMed ID: 16098135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif.
    Schaeffer C; Bardoni B; Mandel JL; Ehresmann B; Ehresmann C; Moine H
    EMBO J; 2001 Sep; 20(17):4803-13. PubMed ID: 11532944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomedicine. Do G quartets orchestrate fragile X pathology?
    Moine H; Mandel JL
    Science; 2001 Dec; 294(5551):2487-8. PubMed ID: 11752559
    [No Abstract]   [Full Text] [Related]  

  • 12. A distinct FMRP polysomal population at an advanced stage of mammalian erythropoiesis.
    Beaulieu MA
    Biochem Biophys Res Commun; 2000 Aug; 275(2):608-10. PubMed ID: 10964711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragile X mental retardation protein in plasticity and disease.
    Todd PK; Malter JS
    J Neurosci Res; 2002 Dec; 70(5):623-30. PubMed ID: 12424729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA and microRNAs in fragile X mental retardation.
    Jin P; Alisch RS; Warren ST
    Nat Cell Biol; 2004 Nov; 6(11):1048-53. PubMed ID: 15516998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles.
    Khandjian EW; Huot ME; Tremblay S; Davidovic L; Mazroui R; Bardoni B
    Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13357-62. PubMed ID: 15329415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology of the fragile X mental retardation protein, an RNA-binding protein.
    Khandjian EW
    Biochem Cell Biol; 1999; 77(4):331-42. PubMed ID: 10546896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fragile X mental retardation protein has nucleic acid chaperone properties.
    Gabus C; Mazroui R; Tremblay S; Khandjian EW; Darlix JL
    Nucleic Acids Res; 2004; 32(7):2129-37. PubMed ID: 15096575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragile X mental retardation protein levels increase following complex environment exposure in rat brain regions undergoing active synaptogenesis.
    Irwin SA; Christmon CA; Grossman AW; Galvez R; Kim SH; DeGrush BJ; Weiler IJ; Greenough WT
    Neurobiol Learn Mem; 2005 May; 83(3):180-7. PubMed ID: 15820853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminus of the fragile X mental retardation protein contains a novel domain involved in dimerization and RNA binding.
    Adinolfi S; Ramos A; Martin SR; Dal Piaz F; Pucci P; Bardoni B; Mandel JL; Pastore A
    Biochemistry; 2003 Sep; 42(35):10437-44. PubMed ID: 12950170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNAs that interact with the fragile X syndrome RNA binding protein FMRP.
    Sung YJ; Conti J; Currie JR; Brown WT; Denman RB
    Biochem Biophys Res Commun; 2000 Sep; 275(3):973-80. PubMed ID: 10973830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.